Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Issuance of $350.0 Million of 1.50% Convertible Senior Notes Due 2018
Date:1/30/2013

tive affiliates and other financial institutions (the "hedge counterparties"). The note hedge transactions are expected generally to reduce the potential dilution to Auxilium's common stock and/or offset potential cash payments in excess of the principal amount upon any conversion of Convertible Notes in the event that the market value per share of Auxilium's common stock, as measured under the terms of the note hedge transactions, is greater than the strike price of the note hedge transactions (which corresponds to the initial conversion price of the Convertible Notes and is subject to certain adjustments substantially similar to those contained in the Convertible Notes). In addition, in order to partially offset the cost of the note hedge transactions, Auxilium issued warrants to the hedge counterparties at a higher strike price. The warrants would separately have a dilutive effect to the extent that the market value per share of Auxilium's common stock exceeds the applicable strike price of the warrants.

Auxilium has been advised that, in connection with the note hedge and warrant transactions, the hedge counterparties or their affiliates have entered into, or expect to enter into, various derivative transactions with respect to Auxilium's common stock and may, from time to time, enter into or unwind various derivatives and/or purchase or sell Auxilium's common stock or other securities of Auxilium in secondary market transactions (and are likely to do so during any observation period relating to a conversion of Convertible Notes). These activities may have increased, or could increase (or reduce the size of any decrease in), the price of Auxilium's common stock, and could also cause or avoid an increase or a decrease in the price of Auxilium's common stock at any time prior to the maturity date.

This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of any of the Convertible Note
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
2. Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10, 2012
3. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
4. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
5. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
6. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
7. Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
8. Auxilium Pharmaceuticals to Announce Third Quarter 2012 Results and Conduct Conference Call on Wednesday, November 7, 2012
9. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
10. Auxilium Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes Due 2018
11. Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Conn. , Aug. 21, 2014  Aptuit ... West Lafayette, Indiana , has enhanced ... and characterization of small and large molecules, including ... of the Bruker maXisPlus Q-TOF mass spectrometer. ... Goldman , CEO, Aptuit, said, "The expanded large ...
(Date:8/21/2014)... 2014  eRelevance Corporation ( www.erelevancecorp.com ), a ... it has completed integration with Nextech, a popular ... and Dermatology practices. "Integration allows our ... practices using Nextech," stated Bob Fabbio , ... from the EMR we are able to automatically ...
(Date:8/21/2014)... TORONTO , Aug. 21, 2014 /CNW/ - The Canadian ... a new comic series designed to educate children about the ... epilepsy.  The Medikidz Explain Epilepsy comic series tells ... who is navigating middle school while living with epilepsy. ... 100 Canadians, there is still so much misinformation and lack ...
Breaking Medicine Technology:Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3
... NewCardio, Inc., (OTC BB: NWCI) a cardiac diagnostic technology provider, ... 30, 2011. More details on the financial results are available ... with the Securities and Exchange Commission. Highlights ... global pharmaceutical company for two Phase I drug safety studies, ...
... Millennium HealthCare Inc. (Symbol: MHCC) announced today that ... Oversight Board (PCAOB) accounting firm as the Company,s accountant ... a combination of technology, intellectual capital and experience with ... entrepreneurial spirit and a reputation for excellence.  The Company ...
Cached Medicine Technology:NewCardio Announces Financial Results for Its 2011 Second Quarter 2NewCardio Announces Financial Results for Its 2011 Second Quarter 3NewCardio Announces Financial Results for Its 2011 Second Quarter 4NewCardio Announces Financial Results for Its 2011 Second Quarter 5NewCardio Announces Financial Results for Its 2011 Second Quarter 6NewCardio Announces Financial Results for Its 2011 Second Quarter 7NewCardio Announces Financial Results for Its 2011 Second Quarter 8Millennium HealthCare Inc. Engages KBL, LLP 2
(Date:8/22/2014)... News) -- Many Americans know little about how Ebola is ... outbreak in the United States, a new survey shows. ... there will be a major Ebola outbreak in the United ... family member will get sick with the deadly virus in ... Public Health poll. However, those opinions don,t match reality, ...
(Date:8/22/2014)... NV (PRWEB) August 22, 2014 Mi40x ... uses university-proven research to show people how they can use ... muscle in only a matter of weeks has caught the ... “Ben Pakulski is one of the most well-known bodybuilders in ... the body he has today, that in itself is a ...
(Date:8/22/2014)... August 22, 2014 Paying tuition and ... in the coming year for four nurse educators pursuing ... National League for Nursing Foundation for Nursing Education . ... share $28,000, $10,000 more than in 2013, thanks to ... Endowment and Elizabeth Isaac Marcil Endowment Funds, both donated ...
(Date:8/22/2014)... Wisconsin (PRWEB) August 22, 2014 Mueller ... for Plantar Fasciitis, an exciting new product that provides ... you to stay active while you heal. The package ... is truly a new technology – it is not ... , FasciaDerm® PFTape™ System for Plantar Fasciitis ...
(Date:8/22/2014)... Orange, NJ. August 22, 2014. A new ... that persons with multiple sclerosis (MS) may be ... rehabilitation. The study was epublished ahead of print ... Goverover, Helen Genova, Hali Griswold, Nancy D. Chiaravalloti ... in persons with multiple sclerosis doi: 10.3233/NRE-141113). Self-awareness ...
Breaking Medicine News(10 mins):Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2Health News:Mi40x: Review Exposes Ben Pakulski’s Guide to Packing on Lean Muscle Fast 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 3Health News:Mueller Introduces FasciaDerm® PFTape™ System for Plantar Fasciitis 2Health News:Kessler Foundation study of self-awareness in MS has implications for rehabilitation 2
... report released today reveals that California ranks in the bottom ... and the District of Columbia in the percentage of ... According to "Reading Across the Nation: A Chartbook," prepared by ... the nonprofit Reach Out and Read National Center, only 44.6 ...
... today in a special supplement to the Journal of General ... patients who speak little, if any, English and the impact ... The studies overall report that measurable disparities in quality of ... same language. , Hospitalized Patients Who ...
... An unforgettable evening of good food, ... The 12th Annual Tallahassee,Wine and Food Festival culminates tomorrow evening ... around the world, including,unique varietals from Argentina and South Africa. ... fun-filled sessions about wine:, * Basics of Wine Tasting ...
... 1 Fibromyalgia is the most common,widespread chronic ... than,six million Americans. But, findings from two new ... there is still much to be,learned about this ... public shows nearly half (45%) of respondents,have never ...
... to Postal Service Social Awareness Stamp,Series, WASHINGTON, Nov. ... year to help raise awareness about Alzheimer,s disease,as part ... announced today, on the first day of both National ... "With the Alzheimer,s Awareness commemorative stamp, we,ll ask,Americans to ...
... NexGenix Pharmaceuticals, a privately,held biotechnology company focused on ... disorder neurofibromatosis and related sporadic,tumors, today announced that ... will be presenting at the Acumen BioFin and ... pm on November 5th, 2007,at the New York ...
Cached Medicine News:Health News:Report shows less than half of kids in California are being read to daily 2Health News:Report shows less than half of kids in California are being read to daily 3Health News:JGIM: studies show importance of language services on disparities, quality of care 2Health News:JGIM: studies show importance of language services on disparities, quality of care 3Health News:JGIM: studies show importance of language services on disparities, quality of care 4Health News:JGIM: studies show importance of language services on disparities, quality of care 5Health News:Take a Culinary Trip Around the World for a Good Cause: March of Dimes 2Health News:Medialink Features: The Painful Truth About Fibromyalgia 2Health News:Alzheimer's Disease to be Highlighted on Stamp Next Year 2Health News:NexGenix Pharmaceuticals to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2